These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 14694838)
1. [Awards for research and development of acarbose]. Unger T Med Klin (Munich); 2003 Oct; 98 Suppl 1():18-9. PubMed ID: 14694838 [No Abstract] [Full Text] [Related]
2. [Robert Koch Award for acarbose. Antidiabetic drug prevents myocardial infarct]. MMW Fortschr Med; 2003 Feb; 145(6):59. PubMed ID: 12619367 [No Abstract] [Full Text] [Related]
4. [Galenus von Pergamon Prize and Charity Award 2014. Prizes for innovation and ideas]. Laschet H MMW Fortschr Med; 2014 Nov; 156(19):32. PubMed ID: 25510014 [No Abstract] [Full Text] [Related]
5. [Cooperation between university-industry]. Unger T Med Klin (Munich); 2004 Aug; 99 Suppl 1():1-2. PubMed ID: 15487850 [No Abstract] [Full Text] [Related]
6. [Pain Care Award 2016]. Red MMW Fortschr Med; 2016 Feb; 158(3):73. PubMed ID: 27119716 [No Abstract] [Full Text] [Related]
7. [More room for the prototype]. Krankenpfl J; 2005; 43(4-6):162. PubMed ID: 16171104 [No Abstract] [Full Text] [Related]
8. [Diabetes mellitus, cardiovascular sequelae and acarbose. Introductory Address by the German Diabetes Society]. Schatz H Med Klin (Munich); 2003 Oct; 98 Suppl 1():20. PubMed ID: 14694839 [No Abstract] [Full Text] [Related]
9. [Jury chooses Pain Nurse of the Year 2012]. Pflege Z; 2013 Jan; 66(1):61. PubMed ID: 23394062 [No Abstract] [Full Text] [Related]
11. Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting. Roze S; Valentine WJ; Evers T; Palmer AJ Curr Med Res Opin; 2006 Jul; 22(7):1415-24. PubMed ID: 16834840 [TBL] [Abstract][Full Text] [Related]
12. [Classics with innovative potential noted. The MMW drug prize for inhalative airway therapeutics]. Füessl HS MMW Fortschr Med; 2002 Feb; 144(8):13. PubMed ID: 11910815 [No Abstract] [Full Text] [Related]
13. [The "STOP NIDDM" program--can diabetes in the aged be prevented? An international long-term study revisited; does Acarbose delay or prevent the manifestations of type II diabetes]. Dtsch Med Wochenschr; 1997; 122(38 Suppl):1-4. PubMed ID: 9339148 [No Abstract] [Full Text] [Related]
14. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M; JAMA; 2003 Jul; 290(4):486-94. PubMed ID: 12876091 [TBL] [Abstract][Full Text] [Related]
15. Acarbose-induced generalised erythema multiforme. Kono T; Hayami M; Kobayashi H; Ishii M; Taniguchi S Lancet; 1999 Jul; 354(9176):396-7. PubMed ID: 10437876 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience with acarbose as first line therapy in NIDDM. Fölsch UR Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018 [TBL] [Abstract][Full Text] [Related]
18. A possible interaction of potential clinical interest between digoxin and acarbose. Serrano JS; Jiménez CM; Serrano MI; Balboa B Clin Pharmacol Ther; 1996 Nov; 60(5):589-92. PubMed ID: 8941033 [TBL] [Abstract][Full Text] [Related]
19. A review of the safety and efficacy of acarbose in diabetes mellitus. Yee HS; Fong NT Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075 [TBL] [Abstract][Full Text] [Related]